OneMed Group, a multinational and multichannel distributor of medical supplies, has retained private equity firm 3i Group Plc to explore strategic options including a sale of the company. OneMed, which is based in Sweden with operations across 12 countries in Europe, may fetch 400 million to 500 million euros ($US443 million to $US553 million), according to people with knowledge of the matter.

OneMed sells more than 40,000 products—including OneMed brands evercare surgical supplies, Selefa examination gloves and Batist bandages, as well as products from such manufacturers as 3M, Smith & Nephew, Semperit and ConvaTec—through a OneMed webshop network of e-commerce sites and sales reps. Niklas Alm, head of investor relations, says the majority of OneMed annual sales are through the company’s e-commerce channels.

3i is working with advisers at Jefferies Group on the sale process, which has attracted interest from other companies in the medical industry as well as private equity firms, such as CVC Capital Partners, the sources said, asking not to be identified because the deliberations are private.

Representatives for 3i, Jefferies and CVC declined to comment.

OneMed has annual sales of 400 million euros (US443 million), according to its website. 3i led the buyout of OneMed in December 2010, then acquired Bosman in 2015 to give the firm access to the Dutch market.

advertisement

Sign up for a free subscription to B2BecNews, a twice-weekly newsletter that covers technology and business trends in the growing B2B e-commerce industry. B2BecNews is published by Vertical Web— Media LLC, which also publishes the monthly business magazine Internet Retailer.

Follow us on LinkedIn and be the first to know when new B2BecNews publishes new content.

Favorite